Algert Global LLC Kal Vista Pharmaceuticals, Inc. Transaction History

Algert Global LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$8.95 - $11.35 $27,207 - $34,504	-3,040 Reduced 11.56%	23,250 $224,000
Q2 2023 Aug 14, 2023	SELL	$7.73 - $10.57 $17,160 - $23,465	-2,220 Reduced 7.79%	26,290 $237,000
Q1 2023 May 12, 2023	BUY	$6.3 - $8.39 $179,613 - $239,198	28,510 New	28,510 $224,000
Q1 2021 May 14, 2021	SELL	$14.69 - $42.57 $178,028 - $515,905	-12,119 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$12.88 - $19.47 $27,048 - $40,887	-2,100 Reduced 14.77%	12,119 $230,000
Q3 2020 Nov 16, 2020	BUY	$9.83 - $13.99 $30,374 - $43,229	3,090 Added 27.77%	14,219 $179,000
Q2 2020 Aug 12, 2020	SELL	$6.75 - $12.89 $51,975 - $99,253	-7,700 Reduced 40.89%	11,129 $135,000
Q1 2020 May 13, 2020	BUY	$5.8 - $18.56 $28,188 - $90,201	4,860 Added 34.79%	18,829 $144,000
Q4 2019 Feb 18, 2020	SELL	$10.31 - $17.81 $152,247 - $263,000	-14,767 Reduced 51.39%	13,969 $249,000
Q3 2019 Nov 14, 2019	BUY	$11.6 - $21.67 $47,200 - $88,175	4,069 Added 16.5%	28,736 $333,000
Q2 2019 Aug 14, 2019	BUY	$18.44 - $30.89 $148,921 - $249,467	8,076 Added 48.68%	24,667 $546,000
Q1 2019 May 01, 2019	SELL	$16.51 - $31.1 $45,402 - $85,525	-2,750 Reduced 14.22%	16,591 $475,000
Q4 2018 Feb 01, 2019	BUY	$16.21 - $24.06 $313,517 - $465,344	19,341 New	19,341 $382,000

125

47.8M

551K

110K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $250M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.